Zomedica Corp (ZOM)

Name: Zomedica Corp Financial Statements
Creator: Quarter Results

Healthcare | Drug Manufacturers Specialty Generic

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$10.5M

Net Income

-$4.5M

Operating Margin

-49.3%

Free Cash Flow

-$17.6M

Debt / Assets

9.2%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Zomedica Corp (ZOM).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	10,471,000	8,095,000	6,964,000	6,500,000
Cost of Revenue	3,301,000	2,659,000	2,298,000	2,093,000
Gross Profit	7,170,000	5,436,000	4,666,000	4,407,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	10,691,000	10,258,000	10,815,000	11,269,000
Operating Expenses	12,334,000	12,042,000	12,701,000	13,122,000
Operating Income	-5,164,000	-6,606,000	-8,035,000	-64,548,000
Interest Expense	0	0	0	0
Income Before Tax	-4,744,000	-6,140,000	-7,386,000	-63,866,000
Income Tax Expense	-214,000	-19,000	12,000	-57,000
Net Income	-4,530,000	-6,121,000	-7,398,000	-63,809,000
Per Share
EPS	0.01	-0.01	-0.01	-0.07
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Zomedica Corp (ZOM).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	32,030,000	27,285,000	25,186,000	18,930,000	4,133,123
Cost of Revenue	10,351,000	8,198,000	7,868,000	5,278,000	1,079,052
Gross Profit	21,679,000	19,087,000	17,318,000	13,652,000	3,054,071
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	43,033,000	46,848,000	43,166,000	32,997,000	22,749,080
Operating Expenses	50,199,000	70,140,000	48,910,000	35,575,000	24,428,068
Operating Income	-84,353,000	-51,053,000	-31,592,000	-21,923,000	-21,373,997
Interest Expense	0	0	175,000	1,000	6,054
Income Before Tax	-82,136,000	-47,539,000	-35,860,000	-19,381,000	-20,716,224
Income Tax Expense	-278,000	-557,000	-1,331,000	-2,366,000	-2,333,054
Net Income	-81,858,000	-46,982,000	-34,529,000	-17,015,000	-18,383,170
Per Share
EPS	-0.08	-0.05	-0.04	-0.02	-0.02
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Zomedica Corp (ZOM).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	9,017,000	7,021,000	12,952,000	27,399,000
Short Term Investments	44,239,000	64,332,000	77,545,000	87,693,000
Net Receivables	3,455,000	3,071,000	2,198,000	1,864,000
Inventory	5,545,000	5,058,000	5,123,000	2,746,000
Total Current Assets	64,043,000	81,773,000	99,882,000	123,501,000
Property Plant Equipment	22,935,000	26,200,000	25,294,000	9,166,000
Goodwill and Intangibles	38,808,000	98,094,000	116,944,000	105,778,000
Total Assets	127,039,000	207,360,000	253,197,000	279,610,000
Liabilities
Account Payables	1,718,000	1,929,000	7,668,000	6,698,000
Short Term Debt	717,000	523,000	916,000	1,282,000
Total Current Liabilities	9,449,000	9,331,000	9,032,000	7,811,000
Long Term Debt	0	1,291,000	1,814,000	1,097,000
Total Liabilities	11,642,000	11,696,000	13,180,000	12,218,000
Shareholders Equity
Retained Earnings	-299,773,000	-217,915,000	-170,933,000	-136,404,000
Total Shareholders Equity	115,397,000	195,664,000	240,017,000	267,392,000

Balance sheet annual history for Zomedica Corp (ZOM).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	9,017,000	7,021,000	12,952,000	27,399,000	194,952,208
Short Term Investments	44,239,000	64,332,000	77,545,000	87,693,000	0
Net Receivables	3,455,000	3,071,000	2,198,000	1,864,000	765,499
Inventory	5,545,000	5,058,000	5,123,000	2,746,000	2,847,985
Total Current Assets	64,043,000	81,773,000	99,882,000	123,501,000	200,407,506
Property Plant Equipment	22,935,000	26,200,000	25,294,000	9,166,000	2,525,356
Goodwill and Intangibles	38,808,000	98,094,000	116,944,000	105,778,000	76,807,325
Total Assets	127,039,000	207,360,000	253,197,000	279,610,000	280,399,293
Liabilities
Account Payables	1,718,000	1,929,000	7,668,000	6,698,000	3,225,348
Short Term Debt	717,000	523,000	916,000	1,282,000	414,695
Total Current Liabilities	9,449,000	9,331,000	9,032,000	7,811,000	4,339,700
Long Term Debt	0	1,291,000	1,814,000	1,097,000	964,191
Total Liabilities	11,642,000	11,696,000	13,180,000	12,218,000	9,513,950
Shareholders Equity
Retained Earnings	-299,773,000	-217,915,000	-170,933,000	-136,404,000	-119,391,398
Total Shareholders Equity	115,397,000	195,664,000	240,017,000	267,392,000	270,885,343

Cash flow quarterly history for Zomedica Corp (ZOM).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-81,858,000	-46,982,000	-34,529,000	-17,015,000
Depreciation & Amortization	7,951,000	7,986,000	6,298,000	4,042,000
Stock Based Compensation	2,472,000	2,778,000	6,263,000	7,891,000
Change in Working Capital	0	-1,071,000	19,000	-5,703,000
Operating Cash Flow	-17,649,000	-23,630,000	-15,975,000	-11,670,000
Investing Activities
Capital Expenditure	0	-6,793,000	-11,339,000	-1,026,000
Investments	0	-5,212,000	-4,646,000	-1,026,000
Investing Cash Flow	19,575,000	17,854,000	1,577,000	-155,880,000
Financing Activities
Debt Repayment	0	0	0	0
Common Stock Issued/Repurchased	0	0	0	8,000
Dividends Paid	0	0	0	0
Financing Cash Flow	0	-70,000	0	8,000
Summary
Free Cash Flow	-17,649,000	-30,423,000	-20,621,000	-12,696,000
Net Change in Cash	1,996,000	-5,931,000	-14,447,000	-167,553,000

Cash flow annual history for Zomedica Corp (ZOM).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-81,858,000	-46,982,000	-34,529,000	-17,015,000	-18,383,170
Depreciation & Amortization	7,951,000	7,986,000	6,298,000	4,042,000	1,139,589
Stock Based Compensation	2,472,000	2,778,000	6,263,000	7,891,000	7,092,031
Change in Working Capital	0	-1,071,000	19,000	-5,703,000	-3,875,793
Operating Cash Flow	-17,649,000	-23,630,000	-15,975,000	-11,670,000	-14,275,156
Investing Activities
Capital Expenditure	0	-6,793,000	-11,339,000	-1,026,000	-526,174
Investments	0	-5,212,000	-4,646,000	-1,026,000	-526,174
Investing Cash Flow	19,575,000	17,854,000	1,577,000	-155,880,000	-71,925,368
Financing Activities
Debt Repayment	0	0	0	0	0
Common Stock Issued/Repurchased	0	0	0	8,000	199,525,000
Dividends Paid	0	0	0	0	0
Financing Cash Flow	0	-70,000	0	8,000	219,159,366
Summary
Free Cash Flow	-17,649,000	-30,423,000	-20,621,000	-12,696,000	-14,801,330
Net Change in Cash	1,996,000	-5,931,000	-14,447,000	-167,553,000	132,960,505